These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Increased CX3CL1 in cerebrospinal fluid and ictal serum t-tau elevations in migraine: results from a cross-sectional exploratory case-control study. Süße M; Kloetzer C; Strauß S; Ruhnau J; Overeem LH; Bendig M; Schulze J; Reuter U; Vogelgesang A; Fleischmann R J Headache Pain; 2024 Apr; 25(1):46. PubMed ID: 38561692 [TBL] [Abstract][Full Text] [Related]
9. Biomarkers of Neurological Damage: From Acute Stage to Post-Acute Sequelae of COVID-19. Zingaropoli MA; Pasculli P; Barbato C; Petrella C; Fiore M; Dominelli F; Latronico T; Ciccone F; Antonacci M; Liuzzi GM; Talarico G; Bruno G; Galardo G; Pugliese F; Lichtner M; Mastroianni CM; Minni A; Ciardi MR Cells; 2023 Sep; 12(18):. PubMed ID: 37759493 [No Abstract] [Full Text] [Related]
10. Evaluation of cerebrospinal fluid ubiquitin C-terminal hydrolase-L1, glial fibrillary acidic protein, and neurofilament light protein as novel markers for the diagnosis of neurosyphilis among HIV-negative patients. Chen R; Lin LR; Xiao Y; Ke WJ; Yang TC Int J Infect Dis; 2023 Feb; 127():36-44. PubMed ID: 36400375 [TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid levels of GFAP and pNF-H are elevated in patients with chronic spinal cord injury and neurological deterioration. Holmström U; Tsitsopoulos PP; Holtz A; Salci K; Shaw G; Mondello S; Marklund N Acta Neurochir (Wien); 2020 Sep; 162(9):2075-2086. PubMed ID: 32588294 [TBL] [Abstract][Full Text] [Related]
12. Serum and cerebrospinal fluid brain damage markers neurofilament light and glial fibrillary acidic protein correlate with tick-borne encephalitis disease severity-a multicentre study on Lithuanian and Swedish patients. Veje M; Griška V; Pakalnienė J; Mickienė A; Bremell D; Zetterberg H; Blennow K; Lindquist L; Studahl M Eur J Neurol; 2023 Oct; 30(10):3182-3189. PubMed ID: 37431060 [TBL] [Abstract][Full Text] [Related]
13. A pharmacokinetic and biomarker study of delayed-release dimethyl fumarate in subjects with secondary progressive multiple sclerosis: evaluation of cerebrospinal fluid penetration and the effects on exploratory biomarkers. Edwards KR; Kamath A; Button J; Kamath V; Mendoza JP; Zhu B; Plavina T; Woodward C; Penner N Mult Scler Relat Disord; 2021 Jun; 51():102861. PubMed ID: 33773271 [TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development. Espíndola OM; Brandão CO; Gomes YCP; Siqueira M; Soares CN; Lima MASD; Leite ACCB; Torezani G; Araujo AQC; Silva MTT Int J Infect Dis; 2021 Jan; 102():155-162. PubMed ID: 33127503 [TBL] [Abstract][Full Text] [Related]
15. Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats. Huang XJ; Glushakova O; Mondello S; Van K; Hayes RL; Lyeth BG J Neurotrauma; 2015 Aug; 32(16):1179-89. PubMed ID: 25763798 [TBL] [Abstract][Full Text] [Related]
16. Serum Tau, Neurofilament Light Chain, Glial Fibrillary Acidic Protein, and Ubiquitin Carboxyl-Terminal Hydrolase L1 Are Associated with the Chronic Deterioration of Neurobehavioral Symptoms after Traumatic Brain Injury. Lange RT; Lippa S; Brickell TA; Gill J; French LM J Neurotrauma; 2023 Mar; 40(5-6):482-492. PubMed ID: 36170576 [TBL] [Abstract][Full Text] [Related]
17. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort. Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051 [TBL] [Abstract][Full Text] [Related]
18. Serum tau protein elevation in migraine: a cross-sectional case-control study. Overeem LH; Raffaelli B; Fleischmann R; Süße M; Vogelgesang A; Maceski AM; Papadopoulou A; Ruprecht K; Su W; Koch M; Siebert A; Arkuszewski M; Tenenbaum N; Kuhle J; Reuter U J Headache Pain; 2023 Sep; 24(1):130. PubMed ID: 37726712 [TBL] [Abstract][Full Text] [Related]
19. Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study. Eckerström M; Nilsson S; Zetterberg H; Blennow K; Grahn A Sci Rep; 2020 Dec; 10(1):22400. PubMed ID: 33372192 [TBL] [Abstract][Full Text] [Related]